Cargando…

Validation of the Portuguese Version of the Kansas City Cardiomyopathy Questionnaire-12

The Kansas City Cardiomyopathy Questionnaire-12 (KCCQ-12) is a simple, feasible, and sensitive questionnaire developed in English for assessing the health status (symptoms, function, and quality of life) of patients with heart failure (HF). We aimed to assess the internal consistency and construct v...

Descripción completa

Detalles Bibliográficos
Autores principales: dos Reis, Mariane Cecilia, Nascimento, Juliana Araújo, de Andrade, Geisa Nascimento, Costa, Ana Cláudia de Souza, Takada, Julio Yoshio, Mansur, Antonio de Padua, Bocchi, Edimar Alcides, dos Santos, Gianni Mara Silva, Spertus, John A., Nakagawa, Naomi Kondo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10144930/
https://www.ncbi.nlm.nih.gov/pubmed/37103041
http://dx.doi.org/10.3390/jcdd10040162
_version_ 1785034212107091968
author dos Reis, Mariane Cecilia
Nascimento, Juliana Araújo
de Andrade, Geisa Nascimento
Costa, Ana Cláudia de Souza
Takada, Julio Yoshio
Mansur, Antonio de Padua
Bocchi, Edimar Alcides
dos Santos, Gianni Mara Silva
Spertus, John A.
Nakagawa, Naomi Kondo
author_facet dos Reis, Mariane Cecilia
Nascimento, Juliana Araújo
de Andrade, Geisa Nascimento
Costa, Ana Cláudia de Souza
Takada, Julio Yoshio
Mansur, Antonio de Padua
Bocchi, Edimar Alcides
dos Santos, Gianni Mara Silva
Spertus, John A.
Nakagawa, Naomi Kondo
author_sort dos Reis, Mariane Cecilia
collection PubMed
description The Kansas City Cardiomyopathy Questionnaire-12 (KCCQ-12) is a simple, feasible, and sensitive questionnaire developed in English for assessing the health status (symptoms, function, and quality of life) of patients with heart failure (HF). We aimed to assess the internal consistency and construct validity of the Portuguese version of KCCQ-12. We administered the KCCQ-12, the Minnesota Living Heart Failure (MLHFQ), and the New York Heart Association (NYHA) classification by telephone. Internal consistency was assessed with Cronbach’s Alpha (α-Cronbach) and construct validity with correlations to the MLHFQ and NYHA. Internal consistency was high (α-Cronbach = 0.92 for the Overall Summary score and 0.77–0.85 for the subdomains). Construct validity was supported by finding high correlations between the KCCQ-12 Physical Limitation and the Symptom Frequency domains with the physical domain of the MLHFQ (r = −0.70 and r = −0.76, p < 0.001 for both) and the Overall Summary scale with NYHA classifications (r = −0.72, p < 0.001). The Portuguese version of KCCQ-12 has high internal consistency and shows a convergent construct validity with other measures quantifying the health status of patients with chronic HF and can be used confidently in Brazil for research and clinical care.
format Online
Article
Text
id pubmed-10144930
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-101449302023-04-29 Validation of the Portuguese Version of the Kansas City Cardiomyopathy Questionnaire-12 dos Reis, Mariane Cecilia Nascimento, Juliana Araújo de Andrade, Geisa Nascimento Costa, Ana Cláudia de Souza Takada, Julio Yoshio Mansur, Antonio de Padua Bocchi, Edimar Alcides dos Santos, Gianni Mara Silva Spertus, John A. Nakagawa, Naomi Kondo J Cardiovasc Dev Dis Communication The Kansas City Cardiomyopathy Questionnaire-12 (KCCQ-12) is a simple, feasible, and sensitive questionnaire developed in English for assessing the health status (symptoms, function, and quality of life) of patients with heart failure (HF). We aimed to assess the internal consistency and construct validity of the Portuguese version of KCCQ-12. We administered the KCCQ-12, the Minnesota Living Heart Failure (MLHFQ), and the New York Heart Association (NYHA) classification by telephone. Internal consistency was assessed with Cronbach’s Alpha (α-Cronbach) and construct validity with correlations to the MLHFQ and NYHA. Internal consistency was high (α-Cronbach = 0.92 for the Overall Summary score and 0.77–0.85 for the subdomains). Construct validity was supported by finding high correlations between the KCCQ-12 Physical Limitation and the Symptom Frequency domains with the physical domain of the MLHFQ (r = −0.70 and r = −0.76, p < 0.001 for both) and the Overall Summary scale with NYHA classifications (r = −0.72, p < 0.001). The Portuguese version of KCCQ-12 has high internal consistency and shows a convergent construct validity with other measures quantifying the health status of patients with chronic HF and can be used confidently in Brazil for research and clinical care. MDPI 2023-04-07 /pmc/articles/PMC10144930/ /pubmed/37103041 http://dx.doi.org/10.3390/jcdd10040162 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Communication
dos Reis, Mariane Cecilia
Nascimento, Juliana Araújo
de Andrade, Geisa Nascimento
Costa, Ana Cláudia de Souza
Takada, Julio Yoshio
Mansur, Antonio de Padua
Bocchi, Edimar Alcides
dos Santos, Gianni Mara Silva
Spertus, John A.
Nakagawa, Naomi Kondo
Validation of the Portuguese Version of the Kansas City Cardiomyopathy Questionnaire-12
title Validation of the Portuguese Version of the Kansas City Cardiomyopathy Questionnaire-12
title_full Validation of the Portuguese Version of the Kansas City Cardiomyopathy Questionnaire-12
title_fullStr Validation of the Portuguese Version of the Kansas City Cardiomyopathy Questionnaire-12
title_full_unstemmed Validation of the Portuguese Version of the Kansas City Cardiomyopathy Questionnaire-12
title_short Validation of the Portuguese Version of the Kansas City Cardiomyopathy Questionnaire-12
title_sort validation of the portuguese version of the kansas city cardiomyopathy questionnaire-12
topic Communication
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10144930/
https://www.ncbi.nlm.nih.gov/pubmed/37103041
http://dx.doi.org/10.3390/jcdd10040162
work_keys_str_mv AT dosreismarianececilia validationoftheportugueseversionofthekansascitycardiomyopathyquestionnaire12
AT nascimentojulianaaraujo validationoftheportugueseversionofthekansascitycardiomyopathyquestionnaire12
AT deandradegeisanascimento validationoftheportugueseversionofthekansascitycardiomyopathyquestionnaire12
AT costaanaclaudiadesouza validationoftheportugueseversionofthekansascitycardiomyopathyquestionnaire12
AT takadajulioyoshio validationoftheportugueseversionofthekansascitycardiomyopathyquestionnaire12
AT mansurantoniodepadua validationoftheportugueseversionofthekansascitycardiomyopathyquestionnaire12
AT bocchiedimaralcides validationoftheportugueseversionofthekansascitycardiomyopathyquestionnaire12
AT dossantosgiannimarasilva validationoftheportugueseversionofthekansascitycardiomyopathyquestionnaire12
AT spertusjohna validationoftheportugueseversionofthekansascitycardiomyopathyquestionnaire12
AT nakagawanaomikondo validationoftheportugueseversionofthekansascitycardiomyopathyquestionnaire12